These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 37555786)
1. Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy. Singh K; Natarajan V; Dewar R; Rupert A; Badralmaa Y; Zhai T; Winchester N; Scrimieri F; Smith M; Davis I; Lallemand P; Giglietti A; Hensien J; Buerkert T; Goshu B; Rehm CA; Hu Z; Lane HC; Imamichi H AIDS; 2023 Nov; 37(14):2119-2130. PubMed ID: 37555786 [TBL] [Abstract][Full Text] [Related]
2. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Imamichi H; Dewar RL; Adelsberger JW; Rehm CA; O'Doherty U; Paxinos EE; Fauci AS; Lane HC Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8783-8. PubMed ID: 27432972 [TBL] [Abstract][Full Text] [Related]
3. Persistent HIV-1 transcription during ART: time to reassess its significance? Fombellida-Lopez C; Berkhout B; Darcis G; Pasternak AO Curr Opin HIV AIDS; 2024 May; 19(3):124-132. PubMed ID: 38502547 [TBL] [Abstract][Full Text] [Related]
4. Defective HIV-1 proviruses produce viral proteins. Imamichi H; Smith M; Adelsberger JW; Izumi T; Scrimieri F; Sherman BT; Rehm CA; Imamichi T; Pau A; Catalfamo M; Fauci AS; Lane HC Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3704-3710. PubMed ID: 32029589 [TBL] [Abstract][Full Text] [Related]
5. Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART. Cochrane CR; Angelovich TA; Byrnes SJ; Waring E; Guanizo AC; Trollope GS; Zhou J; Vue J; Senior L; Wanicek E; Eddine JJ; Gartner MJ; Jenkins TA; Gorry PR; Brew BJ; Lewin SR; Estes JD; Roche M; Churchill MJ Ann Neurol; 2022 Oct; 92(4):532-544. PubMed ID: 35867351 [TBL] [Abstract][Full Text] [Related]
6. Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy. Gabuzda D; Yin J; Misra V; Chettimada S; Gelman BB Viruses; 2023 Apr; 15(4):. PubMed ID: 37112989 [TBL] [Abstract][Full Text] [Related]
7. New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals. Martin HA; Kadiyala GN; Telwatte S; Wedrychowski A; Chen TH; Moron-Lopez S; Arneson D; Hoh R; Deeks S; Wong J; Yukl SA J Virol; 2022 Dec; 96(24):e0160522. PubMed ID: 36448806 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy. Cortés-Rubio CN; Salgado-Montes de Oca G; Prado-Galbarro FJ; Matías-Florentino M; Murakami-Ogasawara A; Kuri-Cervantes L; Carranco-Arenas AP; Ormsby CE; Cortés-Rubio IK; Reyes-Terán G; Ávila-Ríos S Clin Epigenetics; 2019 Sep; 11(1):134. PubMed ID: 31519219 [TBL] [Abstract][Full Text] [Related]
9. Intact proviruses are enriched in the colon and associated with PD-1 Vellas C; Nayrac M; Collercandy N; Requena M; Jeanne N; Latour J; Dimeglio C; Cazabat M; Barange K; Alric L; Carrere N; Martin-Blondel G; Izopet J; Delobel P EBioMedicine; 2024 Feb; 100():104954. PubMed ID: 38160480 [TBL] [Abstract][Full Text] [Related]
10. Viral and host mediators of non-suppressible HIV-1 viremia. Mohammadi A; Etemad B; Zhang X; Li Y; Bedwell GJ; Sharaf R; Kittilson A; Melberg M; Crain CR; Traunbauer AK; Wong C; Fajnzylber J; Worrall DP; Rosenthal A; Jordan H; Jilg N; Kaseke C; Giguel F; Lian X; Deo R; Gillespie E; Chishti R; Abrha S; Adams T; Siagian A; Dorazio D; Anderson PL; Deeks SG; Lederman MM; Yawetz S; Kuritzkes DR; Lichterfeld MD; Sieg S; Tsibris A; Carrington M; Brumme ZL; Castillo-Mancilla JR; Engelman AN; Gaiha GD; Li JZ Nat Med; 2023 Dec; 29(12):3212-3223. PubMed ID: 37957382 [TBL] [Abstract][Full Text] [Related]
11. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections. Anderson EM; Simonetti FR; Gorelick RJ; Hill S; Gouzoulis MA; Bell J; Rehm C; Pérez L; Boritz E; Wu X; Wells D; Hughes SH; Rao V; Coffin JM; Kearney MF; Maldarelli F Viruses; 2020 Jan; 12(2):. PubMed ID: 31991737 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. Antar AA; Jenike KM; Jang S; Rigau DN; Reeves DB; Hoh R; Krone MR; Keruly JC; Moore RD; Schiffer JT; Nonyane BA; Hecht FM; Deeks SG; Siliciano JD; Ho YC; Siliciano RF J Clin Invest; 2020 Jul; 130(7):3543-3559. PubMed ID: 32191639 [TBL] [Abstract][Full Text] [Related]
13. Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats. Joseph KW; Halvas EK; Brandt LD; Patro SC; Rausch JW; Chopra A; Mallal S; Kearney MF; Coffin JM; Mellors JW J Virol; 2022 Jul; 96(13):e0012222. PubMed ID: 35674431 [TBL] [Abstract][Full Text] [Related]
14. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy. Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741 [TBL] [Abstract][Full Text] [Related]
15. Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4. Fisher K; Schlub TE; Boyer Z; Rasmussen TA; Rhodes A; Hoh R; Hecht FM; Deeks SG; Lewin SR; Palmer S Front Immunol; 2023; 14():1064346. PubMed ID: 36776833 [TBL] [Abstract][Full Text] [Related]
16. The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs. Botha JC; Demirov D; Gordijn C; Katusiime MG; Bale MJ; Wu X; Wells D; Hughes SH; Cotton MF; Mellors JW; Kearney MF; van Zyl GU mBio; 2023 Aug; 14(4):e0111623. PubMed ID: 37530525 [TBL] [Abstract][Full Text] [Related]
17. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. Hatano H; Jain V; Hunt PW; Lee TH; Sinclair E; Do TD; Hoh R; Martin JN; McCune JM; Hecht F; Busch MP; Deeks SG J Infect Dis; 2013 Jul; 208(1):50-6. PubMed ID: 23089590 [TBL] [Abstract][Full Text] [Related]
18. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence. Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing. Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816 [TBL] [Abstract][Full Text] [Related]
20. Intragenic proviral elements support transcription of defective HIV-1 proviruses. Kuniholm J; Armstrong E; Bernabe B; Coote C; Berenson A; Patalano SD; Olson A; He X; Lin NH; Fuxman Bass JI; Henderson AJ PLoS Pathog; 2021 Dec; 17(12):e1009982. PubMed ID: 34962974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]